vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Synopsys (SNPS). Click either name above to swap in a different company.

Synopsys is the larger business by last-quarter revenue ($2.3B vs $1.2B, roughly 1.8× Alignment Healthcare, Inc.). Synopsys runs the higher net margin — 19.9% vs 0.9%, a 19.0% gap on every dollar of revenue. On growth, Synopsys posted the faster year-over-year revenue change (50.6% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs 16.9%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Synopsys, Inc. is an American multinational electronic design automation (EDA) company headquartered in Sunnyvale, California, that focuses on design and verification of silicon chips, electronic system-level design and verification, and reusable components. Synopsys supplies tools and services to the semiconductor design and manufacturing industry.

ALHC vs SNPS — Head-to-Head

Bigger by revenue
SNPS
SNPS
1.8× larger
SNPS
$2.3B
$1.2B
ALHC
Growing faster (revenue YoY)
SNPS
SNPS
+125.3% gap
SNPS
50.6%
-74.7%
ALHC
Higher net margin
SNPS
SNPS
19.0% more per $
SNPS
19.9%
0.9%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
34.6%
16.9%
SNPS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ALHC
ALHC
SNPS
SNPS
Revenue
$1.2B
$2.3B
Net Profit
$11.4M
$448.7M
Gross Margin
71.0%
Operating Margin
5.4%
Net Margin
0.9%
19.9%
Revenue YoY
-74.7%
50.6%
Net Profit YoY
-59.7%
EPS (diluted)
$2.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
SNPS
SNPS
Q1 26
$1.2B
Q4 25
$1.0B
$2.3B
Q3 25
$993.7M
$1.7B
Q2 25
$1.0B
$1.6B
Q1 25
$926.9M
$1.5B
Q4 24
$701.2M
$1.5B
Q3 24
$692.4M
$1.5B
Q2 24
$681.3M
$1.5B
Net Profit
ALHC
ALHC
SNPS
SNPS
Q1 26
$11.4M
Q4 25
$-11.0M
$448.7M
Q3 25
$3.7M
$242.5M
Q2 25
$15.7M
$345.3M
Q1 25
$-9.1M
$295.7M
Q4 24
$-31.1M
$1.1B
Q3 24
$-26.4M
$408.1M
Q2 24
$-24.0M
$292.1M
Gross Margin
ALHC
ALHC
SNPS
SNPS
Q1 26
Q4 25
71.0%
Q3 25
78.1%
Q2 25
80.2%
Q1 25
81.4%
Q4 24
78.3%
Q3 24
80.9%
Q2 24
79.4%
Operating Margin
ALHC
ALHC
SNPS
SNPS
Q1 26
Q4 25
-1.0%
5.4%
Q3 25
0.8%
9.5%
Q2 25
2.2%
23.5%
Q1 25
-0.6%
17.3%
Q4 24
-3.2%
20.3%
Q3 24
-2.8%
23.6%
Q2 24
-2.7%
22.8%
Net Margin
ALHC
ALHC
SNPS
SNPS
Q1 26
0.9%
Q4 25
-1.1%
19.9%
Q3 25
0.4%
13.9%
Q2 25
1.5%
21.5%
Q1 25
-1.0%
20.3%
Q4 24
-4.4%
74.4%
Q3 24
-3.8%
26.7%
Q2 24
-3.5%
20.1%
EPS (diluted)
ALHC
ALHC
SNPS
SNPS
Q1 26
Q4 25
$-0.04
$2.44
Q3 25
$0.02
$1.50
Q2 25
$0.07
$2.21
Q1 25
$-0.05
$1.89
Q4 24
$-0.15
$7.13
Q3 24
$-0.14
$2.61
Q2 24
$-0.13
$1.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
SNPS
SNPS
Cash + ST InvestmentsLiquidity on hand
$705.6M
$3.0B
Total DebtLower is stronger
$13.5B
Stockholders' EquityBook value
$206.9M
$28.3B
Total Assets
$1.3B
$48.2B
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
SNPS
SNPS
Q1 26
$705.6M
Q4 25
$604.2M
$3.0B
Q3 25
$644.1M
$2.6B
Q2 25
$503.8M
$14.3B
Q1 25
$479.5M
$3.8B
Q4 24
$470.6M
$4.1B
Q3 24
$381.0M
$2.0B
Q2 24
$363.7M
$1.7B
Total Debt
ALHC
ALHC
SNPS
SNPS
Q1 26
Q4 25
$323.2M
$13.5B
Q3 25
$322.7M
$14.3B
Q2 25
$322.3M
$10.1B
Q1 25
$321.9M
Q4 24
$321.4M
Q3 24
$212.0M
Q2 24
$211.7M
Stockholders' Equity
ALHC
ALHC
SNPS
SNPS
Q1 26
$206.9M
Q4 25
$179.3M
$28.3B
Q3 25
$161.9M
$27.6B
Q2 25
$141.0M
$9.9B
Q1 25
$108.1M
$9.3B
Q4 24
$99.9M
$9.0B
Q3 24
$114.5M
$7.7B
Q2 24
$123.7M
$7.2B
Total Assets
ALHC
ALHC
SNPS
SNPS
Q1 26
$1.3B
Q4 25
$1.1B
$48.2B
Q3 25
$1.1B
$48.2B
Q2 25
$1.0B
$23.8B
Q1 25
$895.6M
$13.0B
Q4 24
$782.1M
$13.1B
Q3 24
$692.3M
$11.6B
Q2 24
$716.3M
$11.0B
Debt / Equity
ALHC
ALHC
SNPS
SNPS
Q1 26
Q4 25
1.80×
0.48×
Q3 25
1.99×
0.52×
Q2 25
2.29×
1.01×
Q1 25
2.98×
Q4 24
3.22×
Q3 24
1.85×
Q2 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
SNPS
SNPS
Operating Cash FlowLast quarter
$128.7M
$639.7M
Free Cash FlowOCF − Capex
$605.2M
FCF MarginFCF / Revenue
26.8%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
11.27×
1.43×
TTM Free Cash FlowTrailing 4 quarters
$1.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
SNPS
SNPS
Q1 26
$128.7M
Q4 25
$-50.4M
$639.7M
Q3 25
$144.6M
$671.0M
Q2 25
$29.1M
$275.4M
Q1 25
$16.6M
$-67.5M
Q4 24
$-8.7M
$562.8M
Q3 24
$26.2M
$455.4M
Q2 24
$23.5M
$476.6M
Free Cash Flow
ALHC
ALHC
SNPS
SNPS
Q1 26
Q4 25
$-55.4M
$605.2M
Q3 25
$139.1M
$632.4M
Q2 25
$21.1M
$219.8M
Q1 25
$8.4M
$-108.2M
Q4 24
$-18.0M
$558.4M
Q3 24
$16.9M
$415.4M
Q2 24
$11.8M
$438.2M
FCF Margin
ALHC
ALHC
SNPS
SNPS
Q1 26
Q4 25
-5.5%
26.8%
Q3 25
14.0%
36.3%
Q2 25
2.1%
13.7%
Q1 25
0.9%
-7.4%
Q4 24
-2.6%
37.3%
Q3 24
2.4%
27.2%
Q2 24
1.7%
30.1%
Capex Intensity
ALHC
ALHC
SNPS
SNPS
Q1 26
Q4 25
0.5%
1.5%
Q3 25
0.6%
2.2%
Q2 25
0.8%
3.5%
Q1 25
0.9%
2.8%
Q4 24
1.3%
0.3%
Q3 24
1.3%
2.6%
Q2 24
1.7%
2.6%
Cash Conversion
ALHC
ALHC
SNPS
SNPS
Q1 26
11.27×
Q4 25
1.43×
Q3 25
38.77×
2.77×
Q2 25
1.86×
0.80×
Q1 25
-0.23×
Q4 24
0.51×
Q3 24
1.12×
Q2 24
1.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALHC
ALHC

Segment breakdown not available.

SNPS
SNPS

License And Maintenance$940.7M42%
Other$640.0M28%
Design IP Segment$407.1M18%
KR$236.9M11%
Sales Based Royalties$30.1M1%

Related Comparisons